The OPAT opportunity for beta-lactam individualization

• 主要な著者: Lindsey M. Childs-Kean (著者), Christina G. Rivera (著者), Veena Venugopalan (著者), Madelyn J. Johnson (著者), Erin F. Barreto (著者)
• フォーマット: 図書
• 出版事項: Cambridge University Press, 2024-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Beta-lactam therapeutic drug monitoring has been growing in prevalence in the acute care hospital setting. Expansion of its use to outpatient parenteral antimicrobial therapy requires careful consideration of potential logistical and therapeutic barriers.